Market revenue in 2023 | USD 718.3 million |
Market revenue in 2030 | USD 2,222.3 million |
Growth rate | 17.5% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.18% in 2023. Horizon Databook has segmented the Germany structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
Germany plays a pivotal role in the competitive landscape of the structural heart devices market in Europe, driven by a strong emphasis on innovation and healthcare infrastructure advancements. Notably, Germany has emerged as a frontrunner in the clinical adoption of TAVI within Europe and globally, as highlighted in a report published in the Euro intervention journal.
The country's comprehensive countrywide quality assurance program, which registers all Surgical Aortic Valve Replacements (SAVR) and TAVI procedures since 2008, offers valuable insights into the evolution of aortic valve stenosis treatment.
With over 100,000 TAVI procedures conducted, Germany has established TAVI as the standard of care for elderly patients over 80 years old. The presence of highly skilled multidisciplinary cardiac experts in Germany not only fuels its own market growth but also contributes significantly to the advancement of cardiovascular care across Europe.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Germany structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account